Your browser doesn't support javascript.
loading
Phosphorylation of NHERF1 S279 and S301 differentially regulates breast cancer cell phenotype and metastatic organotropism.
Greco, Maria Raffaella; Bon, Emeline; Rubino, Rosa; Guerra, Lorenzo; Bernabe-Garcia, Manuel; Cannone, Stefania; Cayuela, Maria-Luisa; Ciaccia, Loredana; Marionneau-Lambot, Séverine; Oullier, Thibauld; Fromont, Gaëlle; Guibon, Roseline; Roger, Sébastien; Reshkin, Stephan Joel; Cardone, Rosa Angela.
Afiliação
  • Greco MR; Department of Bioscience, Biotechnology and Biopharmaceutics, University of Bari, Italy.
  • Bon E; Université de Tours, Inserm UMR1069, Nutrition, Croissance et Cancer, Tours, France.
  • Rubino R; Department of Bioscience, Biotechnology and Biopharmaceutics, University of Bari, Italy.
  • Guerra L; Department of Bioscience, Biotechnology and Biopharmaceutics, University of Bari, Italy.
  • Bernabe-Garcia M; Telomerase, Cancer and Aging Group, Research Unit, Department of Surgery, CIBERehd - University Hospital "Virgen de la Arrixaca", Murcia, Spain.
  • Cannone S; Department of Bioscience, Biotechnology and Biopharmaceutics, University of Bari, Italy.
  • Cayuela ML; Telomerase, Cancer and Aging Group, Research Unit, Department of Surgery, CIBERehd - University Hospital "Virgen de la Arrixaca", Murcia, Spain.
  • Ciaccia L; Department of Bioscience, Biotechnology and Biopharmaceutics, University of Bari, Italy.
  • Marionneau-Lambot S; Cancéropôle du Grand Ouest, Nantes, France.
  • Oullier T; Cancéropôle du Grand Ouest, Nantes, France.
  • Fromont G; Université de Tours, Inserm UMR1069, Nutrition, Croissance et Cancer, Tours, France; Centre Hospitalo-Universitaire de Tours, Tours, France.
  • Guibon R; Université de Tours, Inserm UMR1069, Nutrition, Croissance et Cancer, Tours, France; Centre Hospitalo-Universitaire de Tours, Tours, France.
  • Roger S; Université de Tours, Inserm UMR1069, Nutrition, Croissance et Cancer, Tours, France; Institut Universitaire de France, Paris, France. Electronic address: sebastien.roger@univ-tours.fr.
  • Reshkin SJ; Department of Bioscience, Biotechnology and Biopharmaceutics, University of Bari, Italy. Electronic address: stephanjoel.reshkin@uniba.it.
  • Cardone RA; Department of Bioscience, Biotechnology and Biopharmaceutics, University of Bari, Italy.
Biochim Biophys Acta Mol Basis Dis ; 1865(1): 26-37, 2019 01.
Article em En | MEDLINE | ID: mdl-30326259
ABSTRACT
Metastatic cancer cells are highly plastic for the expression of different tumor phenotype hallmarks and organotropism. This plasticity is highly regulated but the dynamics of the signaling processes orchestrating the shift from one cell phenotype and metastatic organ pattern to another are still largely unknown. The scaffolding protein NHERF1 has been shown to regulate the expression of different neoplastic phenotypes through its PDZ domains, which forms the mechanistic basis for metastatic organotropism. This reprogramming activity was postulated to be dependent on its differential phosphorylation patterns. Here, we show that NHERF1 phosphorylation on S279/S301 dictates several tumor phenotypes such as in vivo invasion, NHE1-mediated matrix digestion, growth and vasculogenic mimicry. Remarkably, injecting mice with cells having differential NHERF1 expression and phosphorylation drove a shift from the predominantly lung colonization (WT NHERF1) to predominately bone colonization (double S279A/S301A mutant), indicating that NHERF1 phosphorylation also acts as a signaling switch in metastatic organotropism.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article